F-star Therapeutics, Inc. ROE 2016-2022 | FSTX
Current and historical return on equity (ROE) values for F-star Therapeutics, Inc. (FSTX) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
ROE - Return on Equity Historical Data |
Date |
TTM Net Income |
Shareholder's Equity |
Return on Equity |
2022-09-30 |
$-0.04B |
$0.06B |
-56.05% |
2022-06-30 |
$-0.04B |
$0.07B |
-42.65% |
2022-03-31 |
$-0.03B |
$0.09B |
-35.29% |
2021-12-31 |
$-0.03B |
$0.10B |
-38.63% |
2021-09-30 |
$-0.05B |
$0.09B |
-67.42% |
2021-06-30 |
$-0.04B |
$0.10B |
-75.90% |
2021-03-31 |
$-0.03B |
$0.04B |
-94.12% |
2020-12-31 |
$-0.03B |
$0.04B |
-89.29% |
2020-09-30 |
$-0.02B |
$0.02B |
-112.82% |
2020-06-30 |
$-0.03B |
$0.02B |
-101.96% |
2020-03-31 |
$-0.03B |
$0.03B |
-78.74% |
2019-12-31 |
$-0.02B |
$0.01B |
-60.93% |
2019-09-30 |
$-0.02B |
$0.04B |
-44.44% |
2019-06-30 |
$-0.02B |
$0.05B |
-44.24% |
2019-03-31 |
$-0.02B |
$0.05B |
-46.00% |
2018-12-31 |
$-0.02B |
$0.06B |
-50.83% |
2018-09-30 |
$-0.02B |
$0.06B |
-47.50% |
2018-06-30 |
$-0.02B |
$0.03B |
-64.12% |
2018-03-31 |
$-0.03B |
$0.03B |
-73.24% |
2017-12-31 |
$-0.03B |
$0.04B |
-93.33% |
2017-09-30 |
$-0.03B |
$0.03B |
-113.73% |
2017-06-30 |
$-0.02B |
$0.04B |
-104.76% |
2017-03-31 |
$-0.02B |
$0.01B |
-115.25% |
2016-12-31 |
$-0.02B |
$0.02B |
-121.43% |
2016-09-30 |
$-0.02B |
$0.01B |
-152.00% |
2016-06-30 |
$-0.02B |
$0.02B |
-200.00% |
2016-03-31 |
$-0.02B |
$0.01B |
-336.84% |
2015-12-31 |
$-0.01B |
$0.01B |
-400.00% |